Technology | 2019.06.05
Brain Sentinel, Inc. Announces New FDA 510(k) Clearance for its First-in-Class SPEAC® System Helping Physicians Characterize Seizure Events
Brain Sentinel, Inc., manufacturer of the first FDA-cleared portable seizure monitoring and alerting technology utilizing surface electromyography (sEMG), announced that its SPEAC® System has received a new 510(k) clearance of expanded indications from the U.S. Food and Drug Administration (FDA).
(PRWeb June 05, 2019)
Read the full story at https://www.prweb.com/releases/brain_sentinel_inc_announces_new_fda_510k_clearance_for_its_first_in_class_speac_system_helping_physicians_characterize_seizure_events/prweb16358433.htm
For more information, please visit
https://www.prweb.com/releases/brain_sen[...]izure_events/prweb16358433.htm
